Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sangamo Therapeutics (SGMO) Asset Utilization Ratio (2016 - 2025)

Sangamo Therapeutics (SGMO) has 15 years of Asset Utilization Ratio data on record, last reported at 0.34 in Q3 2025.

  • For Q3 2025, Asset Utilization Ratio fell 33.23% year-over-year to 0.34; the TTM value through Sep 2025 reached 0.34, down 33.23%, while the annual FY2024 figure was 0.43, 10.58% down from the prior year.
  • Asset Utilization Ratio reached 0.34 in Q3 2025 per SGMO's latest filing, down from 0.88 in the prior quarter.
  • Across five years, Asset Utilization Ratio topped out at 0.92 in Q4 2023 and bottomed at 0.09 in Q2 2022.
  • Average Asset Utilization Ratio over 5 years is 0.38, with a median of 0.29 recorded in 2021.
  • Peak YoY movement for Asset Utilization Ratio: surged 718.71% in 2023, then tumbled 80.62% in 2024.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.11 in 2021, then increased by 27.98% to 0.14 in 2022, then surged by 546.14% to 0.92 in 2023, then crashed by 41.77% to 0.53 in 2024, then plummeted by 35.88% to 0.34 in 2025.
  • Per Business Quant database, its latest 3 readings for Asset Utilization Ratio were 0.34 in Q3 2025, 0.88 in Q2 2025, and 0.67 in Q1 2025.